April 7, 2025
CellCarta offers a full range of validated genomic assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with several commercial assays. Contact us for any custom development.
You might also be interested by
Press Releases
Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials
September 24, 2025
More infoCellTalk Blog
B-Cell Populations in Focus: A New Flow Cytometry Assay for Increased Sensitivity in Autoimmune Research
September 19, 2025
Flow Cytometry
More infoCellTalk Blog
Next-Gen Immune Monitoring: The Value of Single-Cell Sequencing
August 12, 2025
More info